Home Contact Sitemap

PedAM

Pediatric Disease Annotations & Medicines




Disease pulmonary hypertension
Phenotype C0024141|systemic lupus erythematosus
Sentences 12
PubMedID- 22983159 To develop a more comprehensive understanding of the clinical and pathological characteristics of pulmonary hypertension associated with systemic lupus erythematosus (ph/sle) in the chinese population, a systematic review of the literature up to 2012 was conducted.
PubMedID- 24599923 pulmonary hypertension in systemic lupus erythematosus: echocardiography-based definitions predict 6-year survival.
PubMedID- 24428867 High levels of uric acid in systemic lupus erythematosus is associated with pulmonary hypertension.
PubMedID- 24263143 pulmonary hypertension in systemic lupus erythematosus: pulmonary thromboembolism is the leading cause.
PubMedID- 22841984 pulmonary hypertension in systemic lupus erythematosus: prevalence, predictors and diagnostic strategy.
PubMedID- 24238697 pulmonary hypertension in systemic lupus erythematosus.
PubMedID- 25750566 pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival.
PubMedID- 21597395 Objective: to detect coronary artery disease in asymptomatic patients with systemic lupus erythematosus and scleroderma associated with pulmonary hypertension, and to determine whether it is focal or diffuse ischemia.
PubMedID- 25119257 A 42-year-old woman was admitted due to systemic lupus erythematosus complicated with glomerulonephritis and pulmonary hypertension.
PubMedID- 23780636 Primary and secondary pulmonary hypertension in systemic lupus erythematosus.
PubMedID- 22084605 Asymptomatic pulmonary hypertension in systemic lupus erythematosus.
PubMedID- 20012052 pulmonary hypertension in systemic lupus erythematosus: relationship with antiphospholipid antibodies and severe disease outcome.

Page: 1